Author: Gibbons P.C.

Gibbons Advises NAIOP Award Winners on “Office/Mixed Use Deal Of The Year ” and “Industrial Deal of the Year”

The New Jersey Chapter of the National Association of Industrial and Office Properties (NAIOP – NJ) has named the development deal between Bayer Healthcare and Vision Equities/Rubenstein Partners as its “Office/Mixed Use Deal of the Year” and Ahold eCommerce’s Pulaski Distribution Center as its “Industrial Deal of the Year.” Gibbons P.C. played a significant role on behalf of Bayer in this deal, and the firm assisted Ahold in its complex transaction.

Obama Administration’s Latest Crackdown on Patent Trolls

We have recently posted on various developments relating to the surge of litigations involving non-practicing entities, or patent assertion entities, also called “patent trolls.” Last week, the Obama administration launched its latest attack on these litigious parties. Last Tuesday, the President issued seven legislative recommendations and five executive orders aimed to reduce the number of patent troll cases being filed in federal court. Those recommendations and orders can be found at the White House’s website.

IPXI Launches Its First Unit License Right Contract Offering

We have been reporting news and developments regarding the Intellectual Property Exchange International, Inc. (IPXI). Yesterday, the IPXI released details of its first Unit License Right (ULR) contract offering, involving among other assets, a portfolio of Philips organic light-emitting diode (OLED) technology patents. Purchasers of each ULR will be granted “the right to manufacture, use, sell, offer to sell or import five square meters of an OLED display for application in any display screen device.” So after many fits and starts, the IPXI, touted as “the world’s first financial exchange for licensing and trading intellectual property (IP) rights,” appears underway.

Gibbons Employment & Labor Law Attorneys Listed as New Jersey Super Lawyers

Several attorneys in the Gibbons Employment & Labor Law Department were listed as leaders in their fields by New Jersey Super Lawyers and New Jersey Super Lawyers Rising Stars for 2013. Overall, 80 lawyers in the firm were featured in these two publications. The following attorneys were listed in Super Lawyers: Christine A. Amalfe, Chair; Kelly Ann Bird, Director; Mitchell Boyarsky, Director; Susan L. Nardone, Director; and Richard S. Zackin, Director.

Gibbons Employment & Labor Law Attorneys Listed as New Jersey Super Lawyers

Several attorneys in the Gibbons Employment & Labor Law Department were listed as leaders in their fields by New Jersey Super Lawyers and New Jersey Super Lawyers Rising Stars for 2013. Overall, 80 lawyers in the firm were featured in these two publications. The following attorneys were listed in Super Lawyers: Christine A. Amalfe, Chair; Kelly Ann Bird, Director; Mitchell Boyarsky, Director; Susan L. Nardone, Director; and Richard S. Zackin, Director.

Managing Counterfeiting Issues in the Pharmaceutical Industry

Pharmaceutical counterfeiting poses a threat to consumers and harms both the reputation and financial condition of pharmaceutical companies. On Tuesday, June 18, the Gibbons Institute of Law, Science & Technology will be hosting “Managing Counterfeiting Issues in the Pharmaceutical Industry,” from 5:00 – 7:00 pm at Seton Hall Law School in Newark, NJ.

NYC Teacher Nearly Loses Job Due to Facebook Comments About Her Students

Recently, a New York City public school teacher nearly lost her job after posting derogatory remarks on her private Facebook page about hating her students, whom she called “devil[‘]s spawns.” Although a hearing officer concluded that her employment should be terminated, the Supreme Court vacated that decision, which a unanimous panel of the Appellate Division affirmed.

Twitter’s Innovative Patent Agreement (“IPA”) is in Play . . . .

Last spring, we reported Twitter’s introduction of a novel employee patent assignment plan called the “Innovator’s Patent Agreement” (“IPA”). In short, the IPA is a patent assignment agreement, or transfer of patent ownership from an inventor/employee to a company, where the inventor retains control over how the patent is used. Twitter’s IPA now is in play.

The Patent Troll Assaults Continue … But To What End?

Somewhere, someone must have taken the famous cartoon of Elmer Fudd, in full hunting regalia, and changed the caption to read, “Shhhhhhhhhhh, I’m hunting Twolls.” (After securing the appropriate IP permissions, of course.) This past fall, we posed the hypothetical question of whether it was open season for patent trolls, euphemistically referred to as non-practicing entities (“NPEs”) or patent assertion entities (“PAEs”), in the wake of the new 35 U.S.C. § 299.